`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`APPLE INC.,
`Petitioner
`
`v.
`
`SMARTFLASH LLC,
`Patent Owner
`______________________
`
`Case CBM2015-00121
`Patent 8,794,516
`______________________
`
`Before the Honorable JENNIFER S. BISK, RAMA G. ELLURU, and GREGG I.
`ANDERSON, Administrative Patent Judges.
`
`
`PETITIONER APPLE INC.’S OPPOSITION TO
`PATENT OWNER’S MOTION TO EXCLUDE UNDER 37 C.F.R. § 42.64(c)
`
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`CBM2015-00121
`Patent 8,794,516
`
`
`
`I. THE BOARD SHOULD NOT EXCLUDE EXHIBITS 1002, 1042, AND
`1046 .................................................................................................................... 2
`II. THE BOARD SHOULD NOT EXCLUDE EXHIBITS 1003-04, 1006-08,
`1011-18, 1025-28, 1036-41, AND 1045 ............................................................ 4
`III. THE BOARD SHOULD NOT EXCLUDE EXHIBIT 1019 ........................... 10
`IV. THE BOARD SHOULD NOT EXCLUDE EXHIBIT 1044 ........................... 13
`
`
`
`
`
`CBM2015-00121
`Patent 8,794,516
`
`
`In response to Patent Owner’s (“PO”) Motion to Exclude (“Mot.”, Pap. 23),
`
`Petitioner respectfully submits that the Board, sitting as a non-jury tribunal with
`
`administrative expertise, is well-positioned to determine and assign appropriate
`
`weight to the evidence presented here, without resorting to formal exclusion that
`
`might later be held reversible error. See, e.g., S.E.C. v. Guenthner, 395 F. Supp. 2d
`
`835, 842 n.3 (D. Neb. 2005); Builders Steel Co. v. Comm’r of Internal Revenue,
`
`179 F.2d 377, 379 (8th Cir. 1950) (vacating Tax Court decision for exclusion of
`
`competent, material evidence); Donnelly Garment Co. v. Nat’l Labor Relations
`
`Bd., 123 F.2d 215, 224 (8th Cir. 1941) (NLRB’s refusal to receive testimonial evi-
`
`dence was denial of due process). See also, e.g., Samuel H. Moss, Inc. v. F.T.C.,
`
`148 F.2d 378, 380 (2d Cir. 1945), cert. denied, 326 U.S. 734 (1945) (“Even in
`
`criminal trials to a jury it is better, nine times out of ten, to admit, than to exclude, .
`
`. . and in such proceedings as these the only conceivable interest that can suffer by
`
`admitting any evidence is the time lost, which is seldom as much as that inevitably
`
`lost by idle bickering about irrelevancy or incompetence.”). But even under strict
`
`application of the Rules of Evidence, cf. 77 Fed. Reg. 48,612, 48,616 (Aug. 14,
`
`2012) (“42.5(a) and (b) permit administrative patent judges wide latitude in admin-
`
`istering the proceedings to balance the ideal of precise rules against the need for
`
`flexibility to achieve reasonably fast, inexpensive, and fair proceedings”), Petition-
`
`er’s evidence here is entirely proper while PO’s objections—many of which have
`1
`
`
`
`
`
`CBM2015-00121
`Patent 8,794,516
`already been rejected by the Board in prior proceedings on related patents—are
`
`baseless.
`
`I.
`
`The Board Should Not Exclude Exhibits 1002, 1042, and 1046
`
`Petitioner did not rely on Exs. 1002, 1042, and 1046 for “evidence of the
`
`content” of the ‘516 (cf. Mot. 2), but rather to show that PO’s and inventor Patrick
`
`Racz’s own characterizations of the subject matter of the ‘516 support Petitioner’s
`
`contention (and the Board’s previous determination) that the ‘516 relates to a fi-
`
`nancial activity or transaction and is a covered business method patent. See Pap. 2
`
`at 27-28. PO’s and Mr. Racz’s characterizations of the subject matter of the ‘516
`
`in another proceeding are not found in the patent itself; thus, contrary to PO’s as-
`
`sertions, Exs. 1002, 1042, and 1046 are not cumulative of the ‘516, and FRE 1004
`
`is inapplicable. Indeed, as PO admits, when confronting this same argument by
`
`PO, the Board declined to exclude the same Ex. 1002 in another proceeding on a
`
`related patent. While determining whether a patent is a CBM patent requires an ex-
`
`amination of the claims, the Board found “[Patent Owner’s] characterization of the
`
`. . . patent in prior proceedings is relevant to the credibility of its characterization
`
`of the . . . patent in this proceeding.” Mot. 3 (citing CBM2015-00016, Pap 56 at
`
`24); see also CBM2014-00102, Pap. 52 at 36; CBM2014-00106, Pap. 52 at 25;
`
`CBM2014-00108, Pap. 50 at 19; CBM2014-00112, Pap. 48 at 24; CBM2015-
`
`00017, Pap. 46 at 22; CBM2015-00028, Pap. 44 at 25; CBM2015-00029, Pap. 43
`
`
`
`2
`
`
`
`CBM2015-00121
`Patent 8,794,516
`at 27; CBM2015-00031, Pap 45 at 29; CBM2015-00032, Pap. 46 at 28-29;
`
`CBM2015-00033, Pap. 40 at 29. The same reasoning applies here.
`
`PO again argues that “[t]here is nothing about Patent Owner’s characteriza-
`
`tion of the ‘516 in this proceeding … that is contradicted by Exhibits 1002, 1042,
`
`and 1046 such that the credibility of Patent Owner’s characterization is at issue”
`
`(Mot. 3-4). But, as the Board found in other proceedings on related patents, “Patent
`
`Owner’s argument misses the point because the credibility of Patent Owner’s char-
`
`acterization is for the Board to weigh after deciding the threshold issue of admissi-
`
`bility.” See, e.g., CBM2015-00016, Pap. 56 at 241; CBM2015-00017, Pap. 46 at
`
`22; see also CBM2015-00028, Pap. 44 at 25-26; CBM2015-00029, Pap. 43 at 27;
`
`CBM2015-00031, Pap. 45 at 29; CBM2015-00032, Pap. 46 at 29; CBM2015-
`
`00033, Pap. 40 at 29. And, contrary to PO’s claim that its characterization of the
`
`‘516 is not at issue here (Mot. 3-4), PO disputes the financial nature of the ‘516,
`
`see Pap. 6 at 43-48; Pap. 17 at 70-74. Therefore, PO’s and Mr. Racz’s admissions,
`
`which contradict PO’s arguments here, should not be excluded. See CBM2015-
`
`00016, Pap. 56 at 24 (“Patent Owner’s characterization of the . . . patent in prior
`
`proceedings is relevant to Patent Owner’s contention in this proceeding that the . . .
`
`patent does not satisfy the ‘financial in nature’ requirement” for a CBM review.);
`
`CBM2015-00017, Pap. 46 at 22-23; CBM2015-00028, Pap. 44 at 26; CBM2015-
`
`1 All emphasis herein is added unless otherwise indicated.
`
`
`
`3
`
`
`
`CBM2015-00121
`Patent 8,794,516
`00029, Pap. 43 at 27; CBM2015-00031, Pap. 45 at 29; CBM2015-00032, Pap. 46
`
`at 29; CBM2015-00033, Pap. 40 at 29.
`
`Further, PO is wrong that Exs. 1002, 1042, and 1046 do not “appear to make
`
`a fact of consequence in determining this action” merely because the Kelly Decla-
`
`ration (Ex. 1019) and the Board’s Institution Decision (Pap. 8) do not cite them.
`
`Mot. 4. As PO admits, Exs. 1002, 1042, and 1046 are cited in the Petition (Pap. 2)
`
`“as support for the ‘516 Patent being ‘financial in nature’ and thus CBM review
`
`eligible.” Mot. 2 (citing Petition at 25-30). And, Ex. 1046 is also cited in Petition-
`
`er’s Reply (Pap. 21) to show that various elements of the challenged claims are not
`
`inventive. See Pap. 21 at 11, 13. Because Exs. 1002, 1042, and 1046 reflect facts
`
`of consequence in determining this action under FRE 401, they are relevant and
`
`should not be excluded.
`
`II.
`
`The Board Should Not Exclude Exhibits 1003-04, 1006-08, 1011-18,
`1025-28, 1036-41, and 1045
`
`Contrary to PO’s assertions, Exs. 1003-04, 1006-08, 1011-18, 1025-28,
`
`1036-41, and 1045 (“Prior Art Exhibits”) are relevant to the Board’s § 101 analy-
`
`sis. As PO admits, when confronting the same argument from PO, the Board de-
`
`clined to exclude similar exhibits in another proceeding on a related patent because
`
`“these exhibits are relevant to the state of the art—whether the technical limitations
`
`of the challenged claim were well-known, routine, and conventional—and thus, to
`
`our § 101 analysis.” Mot. 6 (citing CBM2015-00016, Pap. 56 at 26); see also, e.g.,
`
`
`
`4
`
`
`
`CBM2015-00121
`Patent 8,794,516
`Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 134 S. Ct. 2347, 2357, 2359 (2014); YYZ,
`
`LLC v. Hewlett-Packard Co., No. 13-136-SLR, 2015 WL 5886176, at *8 (D. Del.
`
`Oct. 8, 2015) (“Although the § 101 inquiry is focused on the claim language, ex-
`
`trinsic evidence [, such as prior art,] may be helpful in terms of understanding the
`
`state of the art . . . , and whether the problem to which the patent was directed is
`
`solved using computer technology in unconventional ways.”); CBM2015-00017,
`
`Pap. 46 at 24; CBM2015-00028, Pap. 44 at 27; CBM2015-00029, Pap. 43 at 29;
`
`CBM2015-00031, Pap. 45 at 31; CBM2015-00032, Pap. 46 at 30; CBM2015-
`
`00033, Pap. 40 at 31; CBM2014-00190, Pap. 47 at 29; CBM2014-00192, Pap. 45
`
`at 26; CBM2014-00193, Pap. 45 at 26; CBM2014-00194, Pap. 51 at 28; cf. Versa-
`
`ta Dev. Grp., Inc. v. SAP Am., Inc., 793 F.3d 1306, 1334, 1336 (Fed. Cir. 2015)
`
`(affirming Board’s reliance on petitioner’s expert in determining that claimed steps
`
`were well-known, routine, and conventional and Board’s finding that “claims at
`
`issue do not recite any improvement in computer technology”). Nothing in this
`
`proceeding should change that outcome. Indeed, both the Petition and the Kelly
`
`Declaration rely on Prior Art Exhibits to show (1) the state of the art, (2) that the
`
`basic concept of controlling access based on payment and/or rules—to which the
`
`challenged claims are directed—was well-known in the prior art, and/or (3) that the
`
`elements disclosed by the challenged claims were well-known, routine, and con-
`
`ventional. See, e.g., Pap. 2 at 5-18 (Overview of Field of the Claimed Invention),
`
`
`
`5
`
`
`
`CBM2015-00121
`Patent 8,794,516
`46-47, 50, 54, 56-71 (citing Prior Art Exhibits); Ex. 1019 ¶¶ 23-73 (State of the
`
`Art), 75-78, 82-83, 86-90 (citing Prior Art Exhibits). And, there is no requirement
`
`that the Board’s Institution Decision cite every piece of potentially relevant evi-
`
`dence in its Institution Decisions for the evidence to “make a fact of consequence
`
`in determining this action,” as PO contends. Mot. 6. Further, in its final written
`
`decisions in prior proceedings on related patents, the Board cited prior art refer-
`
`ences in determining patent eligibility. CBM2015-00016, Pap. 56 at 13 (relying on
`
`prior art to show concepts claimed in related patent were known); CBM2015-
`
`00017, Pap. 46 at 17-18 (same); CBM2015-00028, Pap. 44 at 19 (same);
`
`CBM2015-00029, Pap. 43 at 21 (same); CBM2015-00031, Pap. 45 at 22 (same);
`
`CBM2015-00032, Pap. 46 at 22-23 (same); CBM2015-00033, Pap. 40 at 22-23
`
`(same); CBM2014-00190, Pap. 47 at 19-20 (same); CBM2014-00192, Pap. 45 at
`
`13-14 (same); CBM2014-00193, Pap. 45 at 17 (same); CBM2014-00194, Pap. 51
`
`at 19 (same).
`
`PO also puts the cart before the horse in arguing that the Prior Art Exhibits
`
`are not relevant because “[w]hether the technical limitations of the challenged
`
`claim were well-known, routine, and conventional is only relevant after finding
`
`that a claim is directed to an abstract idea and ... [h]ere, the claims at issue are not
`
`directed to an abstract idea.” (Mot. 6-7). It would be nonsensical to exclude the
`
`Prior Art Exhibits before the Board determines whether it needs to perform the
`
`
`
`6
`
`
`
`CBM2015-00121
`Patent 8,794,516
`second step of the Mayo analysis, as PO urges. This is particularly so in light of the
`
`fact that the Board has already determined that a multitude of related claims are di-
`
`rected to an abstract idea. See CBM2015-00016, Pap. 56 at 8-9; CBM2015-00017,
`
`Pap. 46 at 7-9; CBM2015-00028, Pap. 44 at 8-10; CBM2015-00029, Pap. 43 at 9-
`
`11; CBM2015-00031, Pap. 45 at 11-13; CBM2015-00032, Pap. 46 at 11-13;
`
`CBM2015-00033, Pap. 40 at 11-13; CBM2014-00190, Pap. 47 at 8-10; CBM2014-
`
`00192, Pap. 45 at 7-9; CBM2014-00193, Pap. 45 at 8-9; CBM2014-00194, Pap. 51
`
`at 8-9. The Prior Art Exhibits are unquestionably relevant to the § 101 analysis;
`
`there is no basis to exclude them.
`
`Moreover, in arguing that the Prior Art Exhibits should be excluded, PO im-
`
`properly raises for the first time a new substantive argument regarding the Federal
`
`Circuit’s recent decision in Enfish, LLC v. Microsoft Corp., No. 2015-1244, 2016
`
`WL 2756255 (Fed. Cir. May 12, 2016). See Mot. 7; Motorola Mobility LLC v. In-
`
`tellectual Ventures I LLC, IPR2014-00501, Pap. 48 at 31 (“A motion to exclude is
`
`neither a substantive sur-reply, nor a proper vehicle for arguing whether a reply or
`
`supporting evidence is of appropriate scope.”). Even if this analysis were properly
`
`presented in this context, it is wrong, and ignores more analogous cases, such as In
`
`re TLI Communications LLC Patent Litigation, No. 2015-1372, 2016 WL 2865693
`
`(Fed. Cir. May 17, 2016) and Ultramercial, Inc. v. Hulu, LLC, 772 F.3d 709 (Fed.
`
`Cir. 2014). Indeed, contrary to PO’s argument (Mot. 7), the challenged claims
`
`
`
`7
`
`
`
`CBM2015-00121
`Patent 8,794,516
`here are not “directed to an improvement to computer functionality” like the “in-
`
`novative,” “self-referential table for a computer database” claimed in Enfish. 2016
`
`WL 2756255, at *1, *5. Rather, the challenged claims are like the claims held in-
`
`eligible in TLI—another recent decision noticeably absent from PO’s Motion—and
`
`Ultramercial. In TLI, the Federal Circuit distinguished the Enfish claims based on
`
`the fact that the TLI claims, like the challenged claims here, “are directed to the use
`
`of conventional or generic technology in a nascent but well-known environment.”
`
`TLI, 2016 WL 2865693, at *3. Like the TLI claims, and like related claims already
`
`found patent ineligible, the challenged claims “perform[] generic computer func-
`
`tions such as storing, receiving, and extracting data” using “physical components”
`
`(e.g., wireless interface, non-volatile memory, processor, display) that “behave ex-
`
`actly as expected according to their ordinary use” and “merely provide a generic
`
`environment in which to carry out the abstract idea” of controlling access to con-
`
`tent based on payment and/or rules. Id. at *3, *4, *7; see, e.g., Pap. 2 at 49-50, 53-
`
`73; Pap. 21 at 6-13; see also CBM2015-00016, Pap. 56 at 9-17; CBM2015-00017,
`
`Pap. 46 at 9-18; CBM2015-00028, Pap. 44 at 10-20; CBM2015-00029, Pap. 43 at
`
`11-21; CBM2015-00031, Pap. 45 at 13-23; CBM2015-00032, Pap. 46 at 13-23;
`
`CBM2015-00033, Pap. 40 at 13-23; CBM2014-00190, Pap. 47 at 10-20;
`
`CBM2014-00192, Pap. 45 at 9-18; CBM2014-00193, Pap. 45 at 9-17; CBM2014-
`
`00194, Pap. 51 at 10-20; cf. Enfish, 2016 WL 2756255, at *6 (“[T]he self-
`
`
`
`8
`
`
`
`CBM2015-00121
`Patent 8,794,516
`referential table functions differently than conventional database structures.”); cf.
`
`also Bascom Global Internet Servs., Inc. v. AT&T Mobility LLC, No. 15-1763,
`
`2016 WL 3514158, at *1, *6-8 (Fed. Cir. June 27, 2016) (on appeal of granted mo-
`
`tion to dismiss with no underlying factual record, holding claims failed Mayo step
`
`2 because “[o]n this limited record” and “construed in favor of the nonmovant” the
`
`patent-in-suit is directed to technical solution to solve a computer-rooted problem
`
`and “‘improve[s] the performance of the computer system itself’” by “claiming a
`
`technology-based solution … that overcomes existing problems with other Internet
`
`filtering systems”). And, like other related patent claims that the Board already de-
`
`termined are ineligible, the challenged claims here “are like the claims at issue in
`
`Ultramercial,” which “condition and control access based on viewing an adver-
`
`tisement.” See, e.g., CBM2015-00016, Pap. 56 at 17. “Similar to the claims in Ul-
`
`tramercial, the majority of limitations in the challenged claims comprise this ab-
`
`stract concept of conditioning and controlling access to data.” Id.; see also
`
`CBM2015-00017, Pap. 46 at 16; CBM2015-00028, Pap. 44 at 17; CBM2015-
`
`00029, Pap. 43 at 19; CBM2015-00031, Pap. 45 at 20-21; CBM2015-00032, Pap.
`
`46 at 21; CBM2015-00033, Pap. 40 at 20-21; CBM2014-00190, Pap. 47 at 17-18;
`
`CBM2014-00192, Pap. 45 at 17-18; CBM2014-00193, Pap. 45 at 15-16;
`
`CBM2014-00194, Pap. 51 at 17. Read together, Enfish, TLI, and Ultramercial fur-
`
`ther confirm that the challenged claims are ineligible.
`
`
`
`9
`
`
`
`CBM2015-00121
`Patent 8,794,516
`III. The Board Should Not Exclude Exhibit 1019
`
`PO does not dispute Dr. Kelly’s qualifications or competence, and instead
`
`seeks to exclude the Kelly Declaration based on three meritless arguments: (1) his
`
`opinions are not legal opinions and §§ 101 and 112 are “purely legal issues” (Mot.
`
`8-9), (2) he did not “test the method” he used “against known [§ 101] decisions” to
`
`determine a “false [positive/negative] rate” (Mot. 10-11), and (3) his opinions “re-
`
`flect an analysis that looks for an inventive concept over the prior art, rather than
`
`over the abstract idea itself” (Mot. 12 (emph. orig.)).
`
`First, the Board has already rejected PO’s argument that expert opinions are
`
`not relevant to § 101 issues in other proceedings on related patents, finding that an
`
`expert’s opinions on § 101 “relate to the underlying factual issues related to patent
`
`eligibility.” CBM2015-00016, Pap. 56 at 28; CBM2015-00017, Pap. 46 at 26;
`
`CBM2015-00028, Pap. 44 at 30-31; CBM2015-00029, Pap. 43 at 31-32;
`
`CBM2015-00031, Pap. 45 at 33-34; CBM2015-00032, Pap. 46 at 32-33;
`
`CBM2015-00033, Pap. 40 at 33-34; CBM2014-00190, Pap. 47 at 26-27;
`
`CBM2014-00192, Pap. 45 at 24; CBM2014-00193, Pap. 45 at 24; CBM2014-
`
`00194, Pap. 51 at 26-27; see also Accenture Global Servs., GmbH v. Guidewire
`
`Software, Inc., 728 F.3d 1336, 1340-41 (Fed. Cir. 2013) (“Patent eligibility under §
`
`101 presents an issue of law . . . . [that] may contain underlying factual issues.”);
`
`Arrhythmia Research Tech., Inc. v. Corazonix Corp., 958 F.2d 1053, 1055-56
`
`
`
`10
`
`
`
`CBM2015-00121
`Patent 8,794,516
`(Fed. Cir. 1992) (“[D]etermination of [statutory subject matter] may require find-
`
`ings of underlying facts specific to the particular subject matter and its mode of
`
`claiming.”); YYZ, 2015 WL 5886176, at *8; CBM2015-00017, Pap. 46 at 14-15
`
`(citing expert testimony in finding related claims are not directed to an Internet-
`
`specific problem); CBM2015-00028, Pap. 44 at 16 (same); CBM2015-00029, Pap.
`
`43 at 17-18 (same); CBM2015-00031, Pap. 45 at 19 (same); CBM2015-00032,
`
`Pap. 46 at 19-20 (same); CBM2015-00033, Pap. 40 at 19-20 (same); CBM2014-
`
`00190, Pap. 47 at 11-12 (citing expert testimony in finding related claims have no
`
`inventive concept); CBM2014-00192, Pap. 45 at 9 (same); CBM2014-00193, Pap.
`
`45 at 9 (same); CBM2014-00194, Pap. 51 at 10-11 (same); cf. Versata, 793 F.3d at
`
`1334 (affirming Board’s reliance on petitioner’s expert over patent owner’s expert
`
`in determining claimed steps were well-known, routine, and conventional). And
`
`there is no dispute that Dr. Kelly is competent to opine on the factual issues. Cf.
`
`Mot. 8-12. Because Dr. Kelly’s opinions relate to factual issues underlying § 101,
`
`37 C.F.R. § 42.65 is inapplicable, and his opinions should not be excluded.2
`
`Second, there is no support for PO’s argument—indeed, PO cites none—that
`
`
`2 PO also seeks to exclude ¶ 112 of the Kelly Declaration, which reflects Dr.
`
`Kelly’s factual opinions underlying the § 112 inquiry. Because the Board did not
`
`institute review on that ground, and although exclusion of ¶ 112 is unnecessary,
`
`Petitioner would not oppose it.
`
`
`
`11
`
`
`
`CBM2015-00121
`Patent 8,794,516
`experts, such as Dr. Kelly—who is an engineer, not an attorney—are required to
`
`review legal opinions on § 101 or compare the challenged claims to claims ad-
`
`dressed in such legal opinions to determine a false positive or negative rate. Dr.
`
`Kelly analyzed the facts and information relevant to the two-step analysis required
`
`by Mayo. See, e.g., Pap. 21 at 12, 20.
`
`Third, PO misapprehends the law in arguing that the Kelly Declaration
`
`should be excluded because Dr. Kelly looks for an inventive concept over the prior
`
`art, rather than over the abstract idea itself. The relevant inquiry is not, as PO sug-
`
`gests, whether a claim’s “additional features” are inventive over the abstract idea,
`
`but rather whether they provide an inventive concept despite that the claim is di-
`
`rected to an abstract idea. The required determination is whether the elements left
`
`after removing the abstract idea (i.e., “additional features”) amount to an “in-
`
`ventive concept,” such that they “‘transform the nature of the claim’ into a patent-
`
`eligible application.” Alice, 134 S. Ct. at 2355, 2357; see also Mayo Collaborative
`
`Servs. v. Prometheus Labs., Inc., 132 S. Ct. 1289, 1304 (2012) (distinguishing §
`
`101 inquiry from §§ 102 and 103). As stated above, Dr. Kelly performed the cor-
`
`rect analysis required by Mayo. See, e.g., Pap. 21 at 12, 20.
`
`Finally, PO misses the mark in seeking to exclude the portions of the Kelly
`
`Declaration that “rel[y] upon an exhibit that is objected to herein for the reasons set
`
`forth in those objections.” Mot. 12. The only exhibits that are both cited in the
`
`
`
`12
`
`
`
`CBM2015-00121
`Patent 8,794,516
`Kelly Declaration and objected to by PO are the Prior Art Exhibits discussed in §
`
`II, supra. However, as detailed in § II, the Kelly Declaration’s description of the
`
`art at the relevant time is clearly relevant to the § 101 inquiry. For the same rea-
`
`sons the Prior Art Exhibits are relevant, expert analyses of those exhibits are rele-
`
`vant under FRE 401 and should not be excluded. See, e.g., CBM2015-00016, Pap.
`
`56 at 27-28 (“Because this review is under § 101, analyses of the state of the prior
`
`art … is relevant to the second prong of the Alice and Mayo inquiry.”). Dr. Kelly’s
`
`unrebutted conclusions regarding what would be considered well-known, routine,
`
`and conventional (see, e.g., Ex. 1019 §§ VI and VII) are entitled to weight.
`
`IV. The Board Should Not Exclude Exhibit 1044
`
`Contrary to PO’s argument (Mot. 13), the sworn admissions of its expert in
`
`prior proceedings regarding what was well-known at the time of the challenged pa-
`
`tent are relevant to the § 101 inquiry. PO does not dispute that Dr. Katz would
`
`have qualified as a person of ordinary skill in the art (“POSITA”) in the relevant
`
`time period, and, indeed, proffered Dr. Katz as an expert with the knowledge of a
`
`POSITA in prior proceedings on related patents. Therefore, Dr. Katz’s testimony,
`
`which provides further evidence that a POSITA would have understood various el-
`
`ements of the challenged claims to be well-known, routine, and conventional in the
`
`relevant time period, is highly relevant and should not be excluded under FRE 401.
`
`Further, PO’s hearsay argument is inapplicable. The cited portions of Ex.
`
`
`
`13
`
`
`
`CBM2015-00121
`Patent 8,794,516
`1044 are not hearsay at least because they are party admissions under FRE
`
`801(d)(2)(C)3 and 801(d)(2)(D).4 There is no dispute that Dr. Katz was retained by
`
`PO in a prior proceeding involving the same parties to provide expert opinion on
`
`the patentability of related patents, including related questions regarding prior art
`
`and one of ordinary skill, or that he was authorized by PO to provide his sworn
`
`declaration and deposition testimony on PO’s behalf.5 PO unquestionably had the
`
`3 Under FRE 801(d)(2)(C), a statement is not hearsay where it “is offered against
`
`an opposing party and . . . was made by a person whom the party authorized to
`
`make a statement on the subject.” See, e.g., Samaritan Health Ctr. v. Simplicity
`
`Health Care Plan, 459 F. Supp. 2d 786, 799 (E.D. Wis. 2006) (“[B]ecause First
`
`Health proffers its opponent’s expert report against that opponent, the report can be
`
`considered an admission by a party-opponent . . . .”).
`
`4 Under FRE 801(d)(2)(D), a statement is not hearsay where it “was made by the
`
`party’s agent . . . within the scope of that relationship and while it existed.”
`
`5 In addition, the Board may consider, as an analogous situation, that the Federal
`
`Rules of Civil Procedure would allow for Dr. Katz’s prior testimony to be admissi-
`
`ble in a court proceeding under Rule 32, which provides for the admission of a
`
`deposition taken in a prior matter where the parties and subject matter of the in-
`
`stant matter are the same as involved in the prior matter, as is true here. See FRCP
`
`32(a)(1), 32(a)(4)(B), 32(a)(8); see also, e.g., Hub v. Sun Valley Co., 682 F.2d 776,
`
`
`
`14
`
`
`
`CBM2015-00121
`Patent 8,794,516
`opportunity and motive at the deposition to cross-examine Dr. Katz, its own expert
`
`providing sworn testimony on its behalf, on those topics. Further, PO has been on
`
`notice since the filing of the Petition that Petitioner intended to rely on Dr. Katz’s
`
`admissions, but chose not to seek deposition or otherwise take discovery of Dr.
`
`Katz in this proceeding. And, even if Dr. Katz’s admissions were hearsay (they are
`
`not), they are subject to FRE 807’s residual hearsay exception.6 Although other
`
`evidence demonstrates that the challenged claims are not inventive, Dr. Katz’s ad-
`
`missions are highly probative, given that PO—who hired and proffered Dr. Katz as
`
`an expert on these subjects—cannot credibly deny them. And, as noted above, Dr.
`
`Katz’s sworn testimony is certainly sufficiently trustworthy and its admission
`
`would serve the interests of justice. For the foregoing reasons, PO’s most recent
`
`attempts to exclude this relevant, admissible evidence should again be rejected.
`
`
`
`July 5, 2016
`
`
`
`
`778 (9th Cir. 1982) (Rule 32(a)(8) requirements should be “construed liberally.”).
`
`Respectfully submitted,
`By /J. Steven Baughman/
`J. Steven Baughman, Lead Counsel
`
`6 FRE 807 provides that hearsay may be admitted even where not specifically cov-
`
`ered by a hearsay exception where it is sufficiently trustworthy, offered as evi-
`
`dence of material fact, more probative on that point than other evidence that can be
`
`obtained through reasonable efforts, and where admitting it will best serve the pur-
`
`poses of the FRE and the interests of justice.
`
`
`
`15
`
`
`
`CBM2015-00121
`Patent 8,794,516
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing PETITIONER
`
`APPLE INC.’S OPPOSITION TO PATENT OWNER’S MOTION TO EX-
`
`CLUDE was served on July 5, 2016, to the following counsel via e-mail, pursuant
`
`to the parties’ agreement concerning service:
`
`Michael R. Casey
`Wayne M. Helge
`DAVIDSON BERQUIST JACKSON & GOWDEY LLP
`8300 Greensboro Dr., Suite 500
`McLean, VA 22102
`Telephone: (571) 765-7700
`Facsimile: (571) 765-7200
`mcasey@dbjg.com
`whelge@davidsonberquist.com
`SmartFlash-CBM@dbjg.com
`
`Attorneys for Patent Owner Smartflash LLC
`
`/s/ Sharon Lee
`Sharon Lee
`
`
`
`ROPES & GRAY LLP
`
`16